Goldman Sachs Group Inc Cerus Corp Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Cerus Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,110,918 shares of CERS stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,110,918
Previous 1,520,882
38.8%
Holding current value
$2.72 Million
Previous $2.11 Million
40.78%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding CERS
# of Institutions
165Shares Held
139MCall Options Held
100KPut Options Held
16K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl19.2MShares$24.8 Million0.22% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$17.9 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY12.9MShares$16.6 Million0.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$13.8 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT8.53MShares$11 Million0.07% of portfolio
About CERUS CORP
- Ticker CERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 177,090,000
- Market Cap $228M
- Description
- Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...